dichloroacetic acid has been researched along with Urinary Bladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goericke-Pesch, S; Granados-Soler, JL; Kietzmann, M; Klose, K; Müller, P; Murua Escobar, H; Nolte, I; Packeiser, EM; Schille, JT | 1 |
| Altayyar, M; desBordes, C; Lea, MA | 1 |
2 other study(ies) available for dichloroacetic acid and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line.
Topics: Animals; Apoptosis; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dichloroacetic Acid; Dogs; Fibroblasts; Male; Metformin; Mitochondria; Muscle Cells; Oxidative Phosphorylation; Prostatic Neoplasms; Reactive Oxygen Species; Urinary Bladder Neoplasms | 2021 |
Inhibition of Growth of Bladder Cancer Cells by 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one in Combination with Other Compounds Affecting Glucose Metabolism.
Topics: Antimetabolites; Butyrates; Cell Proliferation; Deoxyglucose; Dichloroacetic Acid; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Glucose; Humans; Hypoglycemic Agents; Phenformin; Pyridines; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2015 |